A K Mehta1, T Doherty2, D Broide2, M Croft1,2. 1. Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. 2. Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Abstract
BACKGROUND: Rhinovirus (RV) can exacerbate allergen-driven asthma. However, it has been suggested that serial infections with RV may also lead to asthma-like features in childhood without prior allergen exposure. AIM: We sought to test the effects of RV infection in the absence of allergen challenge on lung tissue remodeling and to understand whether RV induced factors in common with allergen that promote remodeling. METHODS: We infected C57BL/6 mice multiple times with RV in the absence or presence of allergen to assess airway remodeling. We used knockout mice and blocking reagents to determine the participation of LIGHT (TNFSF14), as well as IL-1β and TGF-β, each previously shown to contribute to lung remodeling driven by allergen. RESULTS: Recurrent RV infection without allergen challenge induced an increase in peribronchial smooth muscle mass and subepithelial fibrosis. Rhinovirus (RV) induced LIGHT expression in mouse lungs after infection, and alveolar epithelial cells and neutrophils were found to be potential sources of LIGHT. Accordingly, LIGHT-deficient mice, or mice where LIGHT was neutralized, displayed reduced smooth muscle mass and lung fibrosis. Recurrent RV infection also exacerbated the airway remodeling response to house dust mite allergen, and this was significantly reduced in LIGHT-deficient mice. Furthermore, neutralizing IL-1β or TGF-β also limited subepithelial fibrosis and/or smooth muscle thickness induced by RV. CONCLUSION: Rhinovirus can promote airway remodeling in the absence of allergen through upregulating common factors that also contribute to allergen-associated airway remodeling.
BACKGROUND: Rhinovirus (RV) can exacerbate allergen-driven asthma. However, it has been suggested that serial infections with RV may also lead to asthma-like features in childhood without prior allergen exposure. AIM: We sought to test the effects of RV infection in the absence of allergen challenge on lung tissue remodeling and to understand whether RV induced factors in common with allergen that promote remodeling. METHODS: We infected C57BL/6 mice multiple times with RV in the absence or presence of allergen to assess airway remodeling. We used knockout mice and blocking reagents to determine the participation of LIGHT (TNFSF14), as well as IL-1β and TGF-β, each previously shown to contribute to lung remodeling driven by allergen. RESULTS: Recurrent RV infection without allergen challenge induced an increase in peribronchial smooth muscle mass and subepithelial fibrosis. Rhinovirus (RV) induced LIGHT expression in mouse lungs after infection, and alveolar epithelial cells and neutrophils were found to be potential sources of LIGHT. Accordingly, LIGHT-deficientmice, or mice where LIGHT was neutralized, displayed reduced smooth muscle mass and lung fibrosis. Recurrent RV infection also exacerbated the airway remodeling response to house dust mite allergen, and this was significantly reduced in LIGHT-deficientmice. Furthermore, neutralizing IL-1β or TGF-β also limited subepithelial fibrosis and/or smooth muscle thickness induced by RV. CONCLUSION: Rhinovirus can promote airway remodeling in the absence of allergen through upregulating common factors that also contribute to allergen-associated airway remodeling.
Authors: Marta Kaminska; Susan Foley; Karim Maghni; Claudine Storness-Bliss; Harvey Coxson; Heberto Ghezzo; Catherine Lemière; Ronald Olivenstein; Pierre Ernst; Qutayba Hamid; James Martin Journal: J Allergy Clin Immunol Date: 2009-05-29 Impact factor: 10.793
Authors: Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern Journal: Mucosal Immunol Date: 2009-08-26 Impact factor: 7.313
Authors: G P Rakes; E Arruda; J M Ingram; G E Hoover; J C Zambrano; F G Hayden; T A Platts-Mills; P W Heymann Journal: Am J Respir Crit Care Med Date: 1999-03 Impact factor: 21.405
Authors: Jason L Girkin; Luke M Hatchwell; Adam M Collison; Malcolm R Starkey; Philip M Hansbro; Hideo Yagita; Paul S Foster; Joerg Mattes Journal: Am J Physiol Lung Cell Mol Physiol Date: 2016-11-11 Impact factor: 5.464
Authors: Sejal Saglani; Donald N Payne; Jie Zhu; Zhuo Wang; Andrew G Nicholson; Andrew Bush; Peter K Jeffery Journal: Am J Respir Crit Care Med Date: 2007-08-16 Impact factor: 21.405
Authors: Nathan W Bartlett; Ross P Walton; Michael R Edwards; Juliya Aniscenko; Gaetano Caramori; Jie Zhu; Nicholas Glanville; Katherine J Choy; Patrick Jourdan; Jerome Burnet; Tobias J Tuthill; Michael S Pedrick; Michael J Hurle; Chris Plumpton; Nigel A Sharp; James N Bussell; Dallas M Swallow; Jurgen Schwarze; Bruno Guy; Jeffrey W Almond; Peter K Jeffery; Clare M Lloyd; Alberto Papi; Richard A Killington; David J Rowlands; Edward D Blair; Neil J Clarke; Sebastian L Johnston Journal: Nat Med Date: 2008-02-03 Impact factor: 53.440
Authors: Xilei XuChen; Jered Weinstock; Maria Arroyo; Kyle Salka; Elizabeth Chorvinsky; Karima Abutaleb; Hector Aguilar; Ryan Kahanowitch; Carlos E Rodríguez-Martínez; Geovanny F Perez; Maria J Gutierrez; Gustavo Nino Journal: Front Pediatr Date: 2021-02-26 Impact factor: 3.418
Authors: David S Perlin; Inbal Zafir-Lavie; Lori Roadcap; Shane Raines; Carl F Ware; Garry A Neil Journal: mSphere Date: 2020-08-12 Impact factor: 4.389
Authors: Yajun Shou; Ekaterina Koroleva; Cody M Spencer; Sergey A Shein; Anna A Korchagina; Kizil A Yusoof; Raksha Parthasarathy; Elizabeth A Leadbetter; Armen N Akopian; Amanda R Muñoz; Alexei V Tumanov Journal: Front Immunol Date: 2021-07-15 Impact factor: 7.561